Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Apr;74(4):966-967.
doi: 10.1016/j.jhep.2020.10.001. Epub 2020 Oct 9.

SARS-CoV-2 massive testing: A window of opportunity to catch up with HCV elimination

Javier Crespo  1 , Álvaro Díaz-González  2 , Paula Iruzubieta  2 , Susana Llerena  2 , Joaquín Cabezas  3
Affiliations
Comment

SARS-CoV-2 massive testing: A window of opportunity to catch up with HCV elimination

Javier Crespo et al. J Hepatol. 2021 Apr.
No abstract available

Keywords: COVID-19; Elimination; HCV; Massive test; SARS-CoV-2; Screening.

PubMed Disclaimer

Conflict of interest statement

Conflict of interests The authors declare no conflicts of interest that pertain to this work. Please refer to the accompanying ICMJE disclosure forms for further details.

Comment in

Comment on

  • Hepatic benefits of HCV cure.
    Calvaruso V, Craxì A. Calvaruso V, et al. J Hepatol. 2020 Dec;73(6):1548-1556. doi: 10.1016/j.jhep.2020.08.006. Epub 2020 Aug 7. J Hepatol. 2020. PMID: 32777323 Review.

References

    1. WHO . WHO; Geneva: 2019. Global Health Sector Strategy on Viral Hepatitis 2016-2021.
    1. Calvaruso V., Craxì A. Hepatic benefits of HCV cure. J Hepatol. 2020;73(6):1548–1556. - PubMed
    1. Tajes S.R., Pocurull A., Castillo J., Casanova G., Vega L., Lens S. Hepatitis C-related cirrhosis will be a marginal cause of hospital admissions in the near future. J Hepatol. 2020;73(6):1360–1367. - PubMed
    1. Dinmohamed A.G., Visser O., Verhoeven R.H.A., Louwman M.W.J., van Nederveen F.H., Willems S.M. Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands. Lancet Oncol. 2020;21(6):750–751. - PMC - PubMed
    1. Blach S., Kondili L.A., Aghemo A., Cai Z., Dugan E., Estes C. Impact of COVID-19 on global hepatitis C elimination efforts. J Hepatol. 2021;74(1):31–36. - PMC - PubMed